Healthtech Startups

Lynx Dx develops MyProstateScore 2.0 (MPS2), a urine test that analyzes 18 gene transcripts to predict the presence of clinically significant prostate cancer. The diagnostic can be run as a biomarker-only test or combined with clinical risk factors, generating individualized patient reports for healthcare providers.

1 investor

Lyra Therapeutics develops biocompatible mesh scaffolds for sustained drug delivery to the sinonasal passages, targeting treatment of chronic rhinosinusitis. The company's proprietary platform uses bioabsorbable polymers and engineered matrices to deliver medication over up to six months with a single administration.

1 investor

Lyrica is a pharmaceutical product used to manage fibromyalgia, a chronic condition characterized by widespread pain and fatigue. The page provides patient education about fibromyalgia symptoms and treatment options including medication, self-care, and exercise.

1 investor

Lysol is a consumer disinfecting product brand that manufactures cleaning wipes for use on household and commercial surfaces. The company operates in the consumer health and cleaning products category.

1 investor

Lyterian Therapeutics develops pharmaceutical treatments by leveraging protein homeostatic mechanisms to target genetically-validated disease drivers. The company focuses on transformative medicines for patients across multiple disease areas.

1 investor

Lythouse builds a unified software application for organizational safety, letting enterprises monitor critical incidents and alerts related to their organization from a single dashboard.

1 investor

M20 Genomics develops single-cell and spatial transcriptome sequencing technologies for life science research, drug discovery, and disease diagnosis applications. The company offers proprietary VITA and NATA product lines based on its M20 Seq and M20 Spatial technologies.

1 investor

Offers devices and services leveraging 3D CZT for real-time radiation imaging in the medical market.

1 investor

MaaT Pharma is a clinical-stage biotech developing microbiome-based therapeutics aimed at improving survival in cancer patients through immune modulation. It operates in the oncology and microbiome therapeutics space.

1 investor

Mabel is a platform for Accountable Care Organizations (ACOs) and health plans that automates voluntary alignment, provider-based beneficiary outreach, health surveys, and CMS compliance reporting. It supports Medicare value-based care programs such as LEAD, ACO REACH, and GUIDE through automated campaign execution, response processing, analytics, and audit-ready communications.

1 investor

MabGenesis is a Japanese startup biopharmaceutical company that commercializes decades of academic antibody research to develop first-in-class and best-in-class therapeutic monoclonal antibody drugs for both human and animal use. Using its MOURA antibody library and IMPACT high-efficiency monoclonal antibody isolation technology, it targets high-unmet-need areas such as cancer and zoonotic diseases, and has built dog and cat antibody libraries for the veterinary drug market.

1 investor

Mable is an Australian online marketplace that connects people seeking disability or aged care support with local independent support workers. Clients can find and book services such as daily living assistance, personal care, nursing, and allied health, and negotiate rates directly with workers.

1 investor

Mablouseblanche is an online medical appointment booking platform that lets patients find and book nearby doctors, pharmacists, dentists and other health professionals. It also offers health professionals a low-cost connected medical scheduling tool, positioned as a cheaper alternative to existing booking software in France.

1 investor

Mach7 Technologies develops medical imaging software platforms and diagnostic viewers for healthcare enterprises, focusing on image workflow, data management, and artificial intelligence integration.

1 investor

machineMD develops technology to improve the measurement and early diagnosis of brain function and disorders. The company serves healthcare providers and patients seeking accurate, fast neurological diagnosis.

1 investor

Macro Biologics develops biotherapeutic products based on amino acid polymer technology for applications in therapeutics and diagnostics. The company serves the biopharmaceutical and medical device sectors.

1 investor

Macromoltek is a computational drug design company that uses a proprietary platform to produce de novo antibody designs, including against difficult targets not accessible through traditional methods. It serves large biopharmaceutical companies and smaller biotechs.

1 investor

Macrotope engineers protein antigens using its patented MacroAntigen/MAV platform, which tunes antigen conformational dynamics to broaden immune response for vaccine and therapeutic antibody discovery. It develops its own vaccine candidates (including for SARS-CoV-2 and related coronaviruses) and offers antibody discovery services to biopharma partners.

1 investor

macu4 develops functional orthopedic medical devices and services designed to support daily, leisure, and sports activities with pragmatic, comfortable solutions. The company serves orthopedic patients and healthcare markets across the USA, EU, and Switzerland.

1 investor

Genie is an AI tool that generates chemist-grade formulas for consumer products from a user's idea, with a qualified chemist reviewing each formula before manufacturing. It targets people who want to create physical consumer products such as formulated goods.

1 investor

Made for Movement develops medical devices and rehabilitation technologies for people with physical disabilities to enable mobility and physical activity. The company serves patients, therapists, and healthcare facilities offering solutions for both home use and clinical rehabilitation settings.

1 investor

MadeForMed provides software for independent general practitioners and family doctors, including an intelligent phone assistant that filters and routes calls, online and phone appointment booking, patient messaging, teleconsultation, and a medical practice software called Odaiji. The company serves physicians across France, aiming to reduce phone interruptions and administrative load in medical practices.

1 investor

MAG-LAB provides NMR spectroscopy services combined with selective protein isotope labeling techniques to analyze protein-ligand interactions at atomic resolution for drug discovery. It supports pharmaceutical and medicinal chemistry teams in hit finding, hit-to-lead optimization, binding site mapping, and characterizing challenging targets including intrinsically disordered proteins.

1 investor

LeadCare II is a rapid blood test device that identifies lead exposure in children within 3 minutes using a fingerstick sample at the point of care. The product is designed for pediatric practices and healthcare providers to enable early diagnosis and prevent lead poisoning in children, particularly those in homes built before 1978.

1 investor